Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2013 May 31;2013(5):CD007752.
doi: 10.1002/14651858.CD007752.pub3.

Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy

Sally M Reid  1 , Philippa Middleton, Mary C Cossich, Caroline A Crowther, Emily Bain
Affiliations
Meta-Analysis

Interventions for clinical and subclinical hypothyroidism pre-pregnancy and during pregnancy

Sally M Reid et al. Cochrane Database Syst Rev. .

Abstract

Background: Over the last decade there has been enhanced awareness of the appreciable morbidity of thyroid dysfunction, particularly thyroid deficiency. Since treating clinical and subclinical hypothyroidism may reduce adverse obstetric outcomes, it is crucial to identify which interventions are safe and effective.

Objectives: To identify interventions used in the management of hypothyroidism and subclinical hypothyroidism pre-pregnancy or during pregnancy and to ascertain the impact of these interventions on important maternal, fetal, neonatal and childhood outcomes.

Search methods: We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 March 2013).

Selection criteria: Randomised controlled trials (RCTs) and quasi-randomised controlled trials that compared a pharmacological intervention for hypothyroidism and subclinical hypothyroidism pre-pregnancy or during pregnancy with another intervention or placebo.

Data collection and analysis: Two review authors assessed trial eligibility and quality and extracted the data.

Main results: We included four RCTs of moderate risk of bias involving 362 women. In one trial of 115 women, levothyroxine therapy to treat pregnant euthyroid (normal thyroid function) women with thyroid peroxidase antibodies was not shown to reduce pre-eclampsia significantly (risk ratio (RR) 0.61; 95% confidence interval (CI) 0.11 to 3.48) but did significantly reduce preterm birth by 72% (RR 0.28; 95% CI 0.10 to 0.80). Two trials of 30 and 48 hypothyroid women respectively compared levothyroxine doses, but both trials reported only biochemical outcomes. A trial of 169 women compared the trace element selenomethionine (selenium) with placebo and no significant differences were seen for either pre-eclampsia (RR 1.44; 95% CI 0.25 to 8.38) or preterm birth (RR 0.96; 95% CI 0.20 to 4.61). None of the four trials reported on childhood neurodevelopmental delay.There was a non-significant trend towards fewer miscarriages with levothyroxine, and selenium showed some favourable impact on postpartum thyroid function and a decreased incidence of moderate to advanced postpartum thyroiditis.

Authors' conclusions: This review found no difference between levothyroxine therapy and a control for treating pregnant euthyroid women with thyroid peroxidase antibodies for the outcome of pre-eclampsia, however a reduction in preterm birth and a trend towards reduced miscarriage with levothyroxine was shown. This review also showed no difference for pre-eclampsia or preterm birth when selenium was compared with placebo, however a promising reduction in postpartum thyroiditis was shown. Childhood neurodevelopmental delay was not assessed by any trial included in the review.Given that this review is based on four trials of moderate risk of bias, with only two trials contributing data (n = 284), there is insufficient evidence to recommend the use of one intervention for clinical or subclinical hypothyroidism pre-pregnancy or during pregnancy over another, for improving maternal, fetal, neonatal and childhood outcomes.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
2
2
Methodological quality summary: review authors' judgements about each methodological quality item for each included study.
1.1
1.1. Analysis
Comparison 1 Levothyroxine versus no treatment, Outcome 1 Pre‐eclampsia.
1.2
1.2. Analysis
Comparison 1 Levothyroxine versus no treatment, Outcome 2 Preterm birth.
1.3
1.3. Analysis
Comparison 1 Levothyroxine versus no treatment, Outcome 3 Miscarriage (first trimester).
1.4
1.4. Analysis
Comparison 1 Levothyroxine versus no treatment, Outcome 4 Gestational hypertension.
1.5
1.5. Analysis
Comparison 1 Levothyroxine versus no treatment, Outcome 5 Placental abruption.
2.1
2.1. Analysis
Comparison 2 Selenomethionine versus placebo, Outcome 1 Pre‐eclampsia.
2.2
2.2. Analysis
Comparison 2 Selenomethionine versus placebo, Outcome 2 Preterm birth.
2.3
2.3. Analysis
Comparison 2 Selenomethionine versus placebo, Outcome 3 Miscarriage.
2.4
2.4. Analysis
Comparison 2 Selenomethionine versus placebo, Outcome 4 Hypothyroidism (2 months after birth and after stopping levothyroxine).
2.5
2.5. Analysis
Comparison 2 Selenomethionine versus placebo, Outcome 5 Postpartum thyroid dysfunction (within 12 months post delivery).
2.6
2.6. Analysis
Comparison 2 Selenomethionine versus placebo, Outcome 6 Hypothyroidism (12 months post delivery).
2.7
2.7. Analysis
Comparison 2 Selenomethionine versus placebo, Outcome 7 Thyroiditis (moderate or advanced at end of postpartum period).
2.8
2.8. Analysis
Comparison 2 Selenomethionine versus placebo, Outcome 8 Thyroiditis (mild, moderate or advanced at end of postpartum period).
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Negro 2006 {published and unpublished data}
    1. Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. Journal of Clinical Endocrinology and Metabolism 2006;91(7):2587‐91. - PubMed
Negro 2007 {published and unpublished data}
    1. Negro R, Greco G, Mangieri T, Pezzarossa P, Dazzi D, Hassan H. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. Journal of Clinical Endocrinology and Metabolism 2007;92(4):1263‐8. - PubMed
Rotondi 2004 {published and unpublished data}
    1. Rotondi M, Mazziotti G, Sorvillo F, Piscopo M, Cioffi M, Amato G, et al. Effects of increased thyroxine dosage pre‐conception on thyroid function during early pregnancy. European Journal of Endocrinology 2004;151:695‐700. - PubMed
Yassa 2010 {published data only}
    1. Yassa L, Marqusee E, Fawcett R, Alexander EK. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial. Journal of Clinical Endocrinology and Metabolism 2010;95(7):3234‐41. - PubMed

References to studies excluded from this review

Harris 2002 {published and unpublished data}
    1. Harris B, Oretti R, Lazarus J, Parkes A, John R, Richards C, et al. Randomised trial of thyroxine to prevent postnatal depression in thyroid‐antibody‐positive women. British Journal of Psychiatry 2002;180:327‐30. - PubMed
Lazarus 2012 {published and unpublished data}
    1. Lazarus JH. Randomised controlled trial of the effect of gestational thyroid hormone intervention therapy on childhood development. http://www.controlled‐trials.com/ISRCTN46178175/ (accessed 21 June 2007).
    1. Lazarus JH, Bestwick JP, Channon S, Paradice R, Maina A, Rees R, et al. Antenatal thyroid screening and childhood cognitive function. New England Journal of Medicine 2012;366(6):493‐501. - PMC - PubMed
Negro 2010 {published data only}
    1. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro‐Green A. Universal screening versus case finding for detection and treatment of thyroid hormonal dysfunction during pregnancy. Journal of Clinical Endocrinology and Metabolism 2010;95(4):1699‐707. - PubMed
Petri 2011 {unpublished data only}
    1. Petri M. Levothyroxine in pregnant SLE patients. ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 15 February 2011).

References to ongoing studies

Spong 2008 {unpublished data only}
    1. Spong CY. Thyroid therapy for mild thyroid deficiency in pregnancy. ClinicalTrials.gov (http://clinicaltrials.gov/) (accessed 20 February 2008).

Additional references

Abalovich 2002
    1. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002;12(1):63‐8. - PubMed
Abalovich 2007
    1. Abalovich M, Amino N, Barbour L, Cobin RH, Groot LJ, Glinoer D, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2007;92(8 Suppl):S1‐S47. - PubMed
Angermayr 2004
    1. Angermayr L, Clar C. Iodine supplementation for preventing iodine deficiency disorders in children. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD003819.pub2] - DOI - PubMed
Cao 1994
    1. Cao XY, Jiang XM, Dou ZH, Rakeman MA, Zhang ML, O'Donnell K, et al. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. New England Journal of Medicine 1994;331(26):1739‐44. - PubMed
Casey 2006
    1. Casey BM, Leveno KJ. Thyroid disease in pregnancy. Obstetrics and Gynecology 2006;108(5):1283‐92. - PubMed
Casey 2007
    1. Casey BM, Dashe JS, Spong CY, McIntire DD, Leveno KJ, Cunningham GF. Perinatal significance of isolated maternal hypothyroxinemia identified in the first half of pregnancy. Obstetrics and Gynecology 2007;109(5):1129‐35. - PubMed
Cleary‐Goldman 2006
    1. Cleary‐Goldman J, Malone FD, Messerlian G, Sullivan L, Canick J. Subclinical hypothyroidism and pregnancy outcomes. American Journal of Obstetrics and Gynecology 2006;193:S3.
Contempre 1993
    1. Contempre B, Duale NL, Dumont JE, Ngo B, Diplock AT, Vanderpas J. Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clinical Endocrinology 1993;36:579‐83. - PubMed
Davis 1988
    1. Davis LE, Leveno KJ, Cunningham GF. Hypothyroidism complicating pregnancy. Obstetrics and Gynecology 1988;72(1):108‐13. - PubMed
Gharib 2005
    1. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT, et al. Consensus Statement #1: Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. Thyroid 2005;15(1):24‐8. - PubMed
Haddow 1999
    1. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New England Journal of Medicine 1999;341(8):549‐56. - PubMed
Harborne 2004
    1. Harborne LR, Alexander CE, Thomson AJ, O'Reilly DSJ, Greer IA. Outcomes of pregnancy complicated by thyroid disease. Australian and New Zealand Journal of Obstetrics and Gynaecology 2005;45:239‐42. - PubMed
Higgins 2011
    1. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Jameson 2008
    1. Jameson JL, Weetman AP. Disorders of the thyroid gland. Harrison’s Principles of Internal Medicine. 17th Edition. USA: Blackwell Publishing, 2008:2224‐47.
Lazarus 2005
    1. Lazarus JH. Thyroid disorders associated with pregnancy: etiology, diagnosis and management. Treatments in Endocrinology 2005;4(1):31‐41. - PubMed
Leung 1993
    1. Leung AS, Lynne KM, Koonings PP, Montoro M, Mestman JH. Perinatal outcome in hypothyroid pregnancies. Obstetrics and Gynecology 1993;81(3):349‐52. - PubMed
Man 1969
    1. Man EB, Jones WS. Thyroid function in human pregnancy: incidence of maternal serum low butanol extractable iodines and of normal gestational TBG and TBPA capacities: retardation of 8‐month‐old infants. American Journal of Obstetrics and Gynecology 1969;104:898‐908. - PubMed
McElduff 2008
    1. McElduff A, Morris J. Thyroid function tests and thyroid antibodies in an unselected population of women undergoing first trimester screening for aneuploidy. Australian and New Zealand Journal of Obstetrics and Gynaecology 2008;48(5):478‐80. - PubMed
Pop 1999
    1. Pop VJ, Kuijpens JL, Baar AL, Verkerk G, Son MM, Vijlder JJ, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clinical Endocrinology 1999;50(2):149‐55. - PubMed
Premawardhana 2000
    1. Premawardhana LD, Parkes LD, Ammari F, John R, Darke C, Adams H, et al. Postpartum thyroiditis and long‐term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. Journal of Clinical Endocrinology and Metabolism 2000;85:71‐5. - PubMed
RevMan 2011 [Computer program]
    1. The Nordic Cochrane Center, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Center, The Cochrane Collaboration, 2011.
Wu 2002
    1. Wu T, Liu GJ, Li P, Clar C. Iodised salt for preventing iodine deficiency disorders. Cochrane Database of Systematic Reviews 2002, Issue 3. [DOI: 10.1002/14651858.CD003204] - DOI - PMC - PubMed

References to other published versions of this review

Reid 2010
    1. Reid SM, Middleton P, Cossich MC, Crowther CA. Interventions for clinical and subclinical hypothyroidism in pregnancy. Cochrane Database of Systematic Reviews 2010, Issue 7. [DOI: 10.1002/14651858.CD007752.pub2] - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources